Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking
Authors:
- 1 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 12 (4) , 416-422
Abstract
The biobehavioral mechanism(s) mediating bupropion's efficacy are not well understood. Behavioral economic measures such as demand curves have proven useful in investigations of the reinforcing effects of drugs of abuse. Behavioral economic measures may also be used to measure the effect of pharmacotherapies on the reinforcing effects of drugs of abuse. The effects of bupropion on simulated demand for cigarettes were investigated in a placebo-controlled double-blind clinical trial. Participants reported the number of cigarettes they would purchase and consume in a single day at a range of prices. The effects of medication on the subjective effects of smoking were also explored. Demand for cigarettes was well described by an exponential demand equation. Bupropion did not significantly decrease the maximum number of cigarettes that participants said they would smoke in a single day nor did it significantly alter the relation between price per cigarette and demand. Baseline demand elasticity did not predict smoking cessation, but changes in elasticity following 1 week of treatment did. Medication group had no effect on any subjective effects of smoking. Bupropion had no significant effects on demand for cigarettes. The exponential demand equation, recently introduced in behavioral economics, proved amenable to human simulated demand and might be usefully employed in other pharmacotherapy studies as it provides a potentially useful measure of changes in the essential value of the drug as a reinforcer. Such changes may be useful in predicting the efficacy of medications designed to reduce drug consumption.Keywords
This publication has 42 references indexed in Scilit:
- Latent structure of facets of alcohol reinforcement from a behavioral economic demand curvePsychopharmacology, 2008
- Decreased Volume of the Brain Reward System in AlcoholismBiological Psychiatry, 2008
- Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in ratsNicotine & Tobacco Research, 2008
- Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects.Journal of Abnormal Psychology, 2008
- A behavioral economic measure of demand for alcohol predicts brief intervention outcomesDrug and Alcohol Dependence, 2007
- Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shellEuropean Journal of Neuroscience, 2007
- Tolerance does not develop to the decrease in nicotine self‐administration produced by repeated bupropion administrationNicotine & Tobacco Research, 2005
- Predicting natural resolution of alcohol-related problems: A prospective behavioral economic analysis.Experimental and Clinical Psychopharmacology, 2002
- Modeling drug consumption in the clinic using simulation procedures: Demand for heroin and cigarettes in opioid-dependent outpatients.Experimental and Clinical Psychopharmacology, 1999
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991